Works about RIVASTIGMINE

Results: 95

Your Medication Information.

Published in:: Brown University Psychopharmacology Update, 2024, v. 35, n. 4, p. 9, doi. 10.1002/pu.31151
Publication type:: Article

Rivastigmine ameliorates indomethacin experimentally induced gastric mucosal injury via activating α7nAChR with inhibiting oxidative stress and apoptosis.

Published in:

Journal of Biochemical & Molecular Toxicology, 2022, v. 36, n. 10, p. 1, doi. 10.1002/jbt.23147

By:

Khalaf, Hanaa M.;
Ahmed, Sabreen M.;
Welson, Nermeen N.;
Abdelzaher, Walaa Yehia

Publication type:

Article

Design and Characterization of Transethosomes loaded with Rivastigmine for Enhanced Transdermal Delivery.

Published in:

Journal of Research in Pharmacy, 2024, v. 28, n. 5, p. 1409, doi. 10.29228/jrp.819

By:

LOBO, Cynthia Lizzie;
PRIYA, Sneh

Publication type:

Article

Safety and efficacy of acetylcholinesterase inhibitors for Alzheimer's disease: A systematic review and meta-analysis.

Published in:

Advances in Clinical & Experimental Medicine, 2024, v. 33, n. 11, p. 1179, doi. 10.17219/acem/176051

By:

Yaqi Gao;
Yulin Liu;
Yanfang Li

Publication type:

Article

Histological Study on the Effect of Rivastigmine and Coconut Oil on the Hippocampus of Experimentally Induced Alzheimer's Disease in Adult Male Albino Rats.

Published in:

Egyptian Journal of Histology, 2023, v. 46, n. 2, p. 723, doi. 10.21608/ejh.2022.114519.1628

By:

Ismail, Zeinab Mohamed Kamel;
Morcos, Mary Attia;
Ragai, Mennatallah Mohamed;
Alghandour, Sarah Mohammed

Publication type:

Article

Donepezil as a safe alternative treatment after maculo‐papular eruption related to rivastigmine in Lewy body disease: a case report and pharmacovigilance data.

Published in:

2024

By:

Chouchana, Margot;
Pinel, Sylvine;
Colboc, Hester;
Soria, Angele;
Buard, Geraldine;
Delage, Clément;
Bloch, Vanessa;
Lilamand, Matthieu

Publication type:

Case Study

The transition from vivid dreams over floccillations and visual hallucinations to complete delirium in a geriatric patient at the dawn of Alzheimer's dementia: beneficial role of rivastigmine.

Published in:

2019

By:

Bonnet, Udo;
Taha, Sarya;
Stuehler, Luidmilla;
Knierim, Uwe

Publication type:

Case Study

Rivastigmine patch for treatment of Alzheimer's disease in clinical practice in Thailand.

Published in:

Psychogeriatrics, 2013, v. 13, n. 1, p. 1, doi. 10.1111/j.1479-8301.2012.00403.x

By:

Kulkantrakorn, Kongkiat;
Tanyakitpisal, Panas;
Towanabut, Somchai;
Dejthevaporn, Charungthai;
Rangseekajee, Poonsri;
Pongpakdee, Sunsanee;
Laptikultham, Somsak;
Rodprasert, Kritsada;
Setthawatcharawanich, Suwanna;
Thinkhamrop, Bandit

Publication type:

Article

Safety and tolerability of rivastigmine transdermal patch formulation in newly diagnosed patients with Alzheimer's dementia in naturalistic conditions.

Published in:

Psychogeriatrics, 2012, v. 12, n. 3, p. 165, doi. 10.1111/j.1479-8301.2011.00400.x

By:

Pregelj, Peter

Publication type:

Article

Directed Evolution and Immobilization of Lactobacillus brevis Alcohol Dehydrogenase for Chemo‐Enzymatic Synthesis of Rivastigmine.

Published in:

Chemistry - A European Journal, 2024, v. 30, n. 32, p. 1, doi. 10.1002/chem.202400454

By:

Su, Guorong;
Ran, Lu;
Liu, Chang;
Qin, Zhaoyang;
Teng, Huailong;
Wu, Shuke

Publication type:

Article

Concise Synthesis of Chiral Tricyclic Lactams by Tandem Dynamic Kinetic Asymmetric Reductive Amination/Lactamization Using Ammonium Salts.

Published in:

Angewandte Chemie, 2023, v. 135, n. 25, p. 1, doi. 10.1002/ange.202303868

By:

Wang, Jingxin;
Shi, Yongjie;
Wang, Fangyuan;
Huang, Fanping;
Bai, Shao‐Tao;
Zhao, Yu;
Zhang, Xumu

Publication type:

Article

Effectiveness of switching to the rivastigmine transdermal patch from oral cholinesterase inhibitors: a naturalistic prospective study in Alzheimer's disease.

Published in:

Neurological Sciences, 2015, v. 36, n. 3, p. 457, doi. 10.1007/s10072-014-2002-3

By:

Cagnin, Annachiara;
Cester, Alberto;
Costa, Bruno;
Ermani, Mario;
Gabelli, Carlo;
Gambina, Giuseppe

Publication type:

Article

Novel Rivastigmine Derivatives as Promising Multi-Target Compounds for Potential Treatment of Alzheimer's Disease.

Published in:

Biomedicines, 2022, v. 10, n. 7, p. N.PAG, doi. 10.3390/biomedicines10071510

By:

Vicente-Zurdo, David;
Rosales-Conrado, Noelia;
León-González, M. Eugenia;
Brunetti, Leonardo;
Piemontese, Luca;
Pereira-Santos, A. Raquel;
Cardoso, Sandra M.;
Madrid, Yolanda;
Chaves, Sílvia;
Santos, M. Amélia

Publication type:

Article

HMTM-Mediated Enhancement of Brain Bioenergetics in a Mouse Tauopathy Model Is Blocked by Chronic Administration of Rivastigmine.

Published in:

Biomedicines, 2022, v. 10, n. 4, p. 867, doi. 10.3390/biomedicines10040867

By:

Santos, Renato X.;
Melis, Valeria;
Goatman, Elizabeth A.;
Leith, Michael;
Baddeley, Thomas C.;
Storey, John M. D.;
Riedel, Gernot;
Wischik, Claude M.;
Harrington, Charles R.

Publication type:

Article

Cognitive effects with rivastigmine augmentation of risperidone: A 12-month, randomized, double-blind, placebo-controlled study in schizophrenia.

Published in:

Indian Journal of Psychiatry, 2017, v. 59, n. 2, p. 219, doi. 10.4103/psychiatry.IndianJPsychiatry_133_16

By:

Kumar, Pattath Narayanan Suresh;
Mohemmedali, Seema P.;
Anish, P. K.;
Andrade, Chittaranjan

Publication type:

Article

Neuroprotection of Cholinergic Neurons with a Tau Aggregation Inhibitor and Rivastigmine in an Alzheimer's-like Tauopathy Mouse Model.

Published in:

Cells (2073-4409), 2024, v. 13, n. 7, p. 642, doi. 10.3390/cells13070642

By:

Zadrozny, Maciej;
Drapich, Patrycja;
Gasiorowska-Bien, Anna;
Niewiadomski, Wiktor;
Harrington, Charles R.;
Wischik, Claude M.;
Riedel, Gernot;
Niewiadomska, Grazyna

Publication type:

Article

Efficacy of rivastigmine transdermal therapy on low food intake in patients with Alzheimer's disease: The Attitude Towards Food Consumption in Alzheimer's Disease Patients Revive with Rivastigmine Effects study.

Published in:

Geriatrics & Gerontology International, 2019, v. 19, n. 7, p. 571, doi. 10.1111/ggi.13644

By:

Tsuno, Norifumi;
Mori, Takahiro;
Ishikawa, Ichiro;
Bando, Nobuyasu;
Park, Haeyoung;
Matsumoto, Yoshito;
Mori, Itsuko;
Tanaka, Mariko;
Hirano, Takayuki;
Nakamura, Yu

Publication type:

Article

Effect of rivastigmine on plasma butyrylcholine esterase activity and plasma ghrelin levels in patients with dementia in Alzheimer’s disease.

Published in:

Geriatrics & Gerontology International, 2018, v. 18, n. 6, p. 886, doi. 10.1111/ggi.13275

By:

Kuroda, Atsushi;
Setoguchi, Manabu;
Uchino, Yasushi;
Nagata, Kazuya;
Hokonohara, Daisuke

Publication type:

Article

Preliminary evidence that rivastigmine-induced inhibition of serum butyrylcholinesterase activity improves behavioral symptoms in Japanese patients with Alzheimer's disease.

Published in:

Geriatrics & Gerontology International, 2017, v. 17, n. 9, p. 1306, doi. 10.1111/ggi.12865

By:

Bando, Nobuyasu;
Nakamura, Yu

Publication type:

Article

Effects on agitation with rivastigmine patch monotherapy and combination therapy with memantine in mild to moderate Alzheimer's disease: a multicenter 24-week prospective randomized open-label study (the Korean EXelon Patch and combination with mEmantine Comparative Trial study)*

Published in:

Geriatrics & Gerontology International, 2017, v. 17, n. 3, p. 494, doi. 10.1111/ggi.12754

By:

Yoon, Soo J;
Choi, Seong H;
Na, Hae R;
Park, Kyung‐Won;
Kim, Eun‐Joo;
Han, Hyun J;
Lee, Jae‐Hong;
Shim, Young S;
Na, Duk L

Publication type:

Article

Sinus arrest as a result of rivastigmine in an elderly dementia with Lewy bodies patient.

Published in:

Geriatrics & Gerontology International, 2015, v. 15, n. 2, p. 229, doi. 10.1111/ggi.12311

By:

Muto, Shigenori;
Kawano, Hiroaki;
Nakatomi, Daisuke;
Yamasa, Toshihiko;
Maemura, Koji

Publication type:

Article

Rivastigmine patch and massage for Alzheimer's disease patients.

Published in:

Geriatrics & Gerontology International, 2013, v. 13, n. 2, p. 515, doi. 10.1111/ggi.12010

By:

Satoh, Sachiko;
Kajiwara, Mutsuko;
Kiyokawa, Emi;
Toukairin, Yoshiko;
Fujii, Masahiko;
Sasaki, Hidetada

Publication type:

Article

Polymeric Microneedles for Transdermal Delivery of Rivastigmine: Design and Application in Skin Mimetic Model.

Published in:

Pharmaceutics, 2022, v. 14, n. 4, p. N.PAG, doi. 10.3390/pharmaceutics14040752

By:

Guimarães, Tânia M. T.;
Moniz, Tânia;
Nunes, Cláudia;
Zaharieva, Maya Margaritova;
Kaleva, Mila;
Yoncheva, Krassimira;
Najdenski, Hristo;
Costa Lima, Sofia A.;
Reis, Salette

Publication type:

Article

The Influence of an Acute Administration of Cannabidiol or Rivastigmine, Alone and in Combination, on Scopolamine-Provoked Memory Impairment in the Passive Avoidance Test in Mice.

Published in:

Pharmaceuticals (14248247), 2024, v. 17, n. 6, p. 809, doi. 10.3390/ph17060809

By:

Kruk-Slomka, Marta;
Slomka, Tomasz;
Biala, Grazyna

Publication type:

Article

The Potential Effect of Insulin on AChE and Its Interactions with Rivastigmine In Vitro.

Published in:

Pharmaceuticals (14248247), 2021, v. 14, n. 11, p. 1136, doi. 10.3390/ph14111136

By:

Jamshidnejad-Tosaramandani, Tahereh;
Kashanian, Soheila;
Babaei, Mahsa;
Al-Sabri, Mohamed H.;
Schiöth, Helgi B.

Publication type:

Article

A very low dose of rivastigmine-induced Pisa syndrome in a clozapine-treated patient.

Published in:

Australian & New Zealand Journal of Psychiatry, 2018, v. 52, n. 2, p. 204, doi. 10.1177/0004867417741983

By:

Pei-Chun Chao;
Juo-Chi Li;
Ta-Chuan Yeh;
Chin-Bin Yeh

Publication type:

Article

Rivastigmine for treatment resistant Post Traumatic stress disorder.

Published in:

Australian & New Zealand Journal of Psychiatry, 2017, v. 51, n. 9, p. 946, doi. 10.1177/0004867417698234

By:

Murray, Alexander;
Wallace, Duncan;
Nielssen, Olav

Publication type:

Article

The Effect of the Acetylcholinesterase Inhibitor Rivastigmine on the Pentylenetetrazole-Induced Kindling Model of Experimental Epilepsy.

Published in:

Acta Physiologica, 2023, v. 237, p. 65

By:

Türkdönmez, Elif;
Okuyucu, Büşra;
Hatipoğlu, Burcu;
Tiryaki, Emre Soner;
Arslan, Gökhan;
Ağar, Erdal;
Ayyıldız, Mustafa

Publication type:

Article

The Effect of Rivastigmine on Spike-Wave Discharges and Interaction with T-Type Calcium Channels in WAG/Rij Rats.

Published in:

Acta Physiologica, 2023, v. 237, p. 34

By:

Türkdönmez, Elif;
Okuyucu, Büşra;
Tiryaki, Emre Soner;
Arslan, Gökhan;
Ağar, Erdal;
Ayyıldız, Mustafa

Publication type:

Article

ISMP Adverse Drug Reactions: Adalimumab-Induced Aseptic Meningitis Pill Desiccant -Induced Acute Hypoxic Respiratory Failure Rivastigmine Patch -Induced Angioedema Acute Liver Failure Due to Etodolac Severe Cognitive Impairment Due to High Free Valproic Acid Levels

Published in:

Hospital Pharmacy, 2018, v. 53, n. 5, p. 292, doi. 10.1177/0018578718794518

By:

Mancano, Michael A.;
Milenki, Kristen J.;
Esordi, Morgan V.;
Patel, Darshil D.

Publication type:

Article

Rivastigmine for ECT-induced cognitive adverse effects in late life depression (RECALL study): A multicenter, randomized, double blind, placebo-controlled, cross-over trial in patients with depression aged 55 years or older: Rationale, objectives and methods

Published in:

Frontiers in Psychiatry, 2022, v. 13, p. 1, doi. 10.3389/fpsyt.2022.953686

By:

Henstra, Marieke J.;
Feenstra, Thomas C.;
Kok, Rob M.;
Spaans, Harm-Pieter;
van Exel, Eric;
Dols, Annemiek;
Oudega, Mardien;
Vergouwen, Anton C. M.;
van der Loo, Adriano;
Bet, Pierre M.;
Loer, Stephan A.;
Eikelenboom, Merijn;
Sienaert, Pascal;
Lambrichts, Simon;
Bouckaert, Filip;
Bosmans, Judith E.;
van der Velde, Nathalie;
Beekman, Aartjan T. F.;
Stek, Max L.;
Rhebergen, Didi

Publication type:

Article

Rivastigmine Transdermal Patch 13.3 mg/24 h: A Review of Its Use in the Management of Mild to Moderate Alzheimer's Dementia.

Published in:

Drugs & Aging, 2014, v. 31, n. 8, p. 639, doi. 10.1007/s40266-014-0197-x

By:

Frampton, James

Publication type:

Article

Development and Characterization of Rivastigmine Hydrogen Tartrate Elementary Osmotic Tablets.

Published in:

International Journal of Pharmaceutical Investigation, 2024, v. 14, n. 1, p. 239, doi. 10.5530/ijpi.14.1.30

By:

Naz, Ayesha;
Subrahmanyam, C. V. S.;
Rachamalla, Shyam Sunder

Publication type:

Article

Analytical Method Development and Validation of Rivastigmine in its Pure and Pharmaceutical Dosage form Using UPLC.

Published in:

International Journal of Pharmaceutical Investigation, 2023, v. 13, n. 3, p. 595, doi. 10.5530/ijpi.13.3.074

By:

Kommu, Aarthi;
Sundararajan, Raja

Publication type:

Article

Pharmacotherapy for Poststroke Cognitive Impairment and Poststroke Cognitive Impairment With Dementia: A Review.

Published in:

Stroke Research & Treatment, 2025, v. 2025, p. 1, doi. 10.1155/srat/6893801

By:

Ravi, Renju;
Das, Saibal;
Hakami, Tahir;
B. M., Prakash;
Pushparajan, Libby;
Stecco, Alessandro

Publication type:

Article

Mitochondrial Effects of Hydromethylthionine, Rivastigmine and Memantine in Tau-Transgenic Mice.

Published in:

International Journal of Molecular Sciences, 2023, v. 24, n. 13, p. 10810, doi. 10.3390/ijms241310810

By:

Kondak, Constantin;
Leith, Michael;
Baddeley, Thomas C.;
Santos, Renato X.;
Harrington, Charles R.;
Wischik, Claude M.;
Riedel, Gernot;
Klein, Jochen

Publication type:

Article

Hypoxic and Hypercapnic Responses in Transgenic Murine Model of Alzheimer's Disease Overexpressing Human AβPP: The Effects of Pretreatment with Memantine and Rivastigmine.

Published in:

International Journal of Molecular Sciences, 2022, v. 23, n. 11, p. 6004, doi. 10.3390/ijms23116004

By:

Andrzejewski, Kryspin;
Jampolska, Monika;
Mojzych, Ilona;
Conde, Silvia V.;
Kaczyńska, Katarzyna

Publication type:

Article

The Impact of a Long-Term Rivastigmine and Donepezil Treatment on All-Cause Mortality in Patients With Alzheimer’s Disease.

Published in:

American Journal of Alzheimer's Disease & Other Dementias, 2018, v. 33, n. 6, p. 385, doi. 10.1177/1533317518775044

By:

Kazmierski, Jakub;
Messini-Zachou, Chaido;
Gkioka, Mara;
Tsolaki, Magda

Publication type:

Article

Which Rivastigmine Formula is Better for Heart in Elderly Patients With Alzheimer’s Disease: Oral or Patch?

Published in:

American Journal of Alzheimer's Disease & Other Dementias, 2014, v. 29, n. 8, p. 735, doi. 10.1177/1533317514536598

By:

Isik, Ahmet Turan;
Soysal, Pinar;
Yay, Adnan

Publication type:

Article

Efficacy of Higher Dose 13.3 mg/24 h Rivastigmine Patch on Instrumental Activities of Daily Living in Patients with Mild-to-Moderate Alzheimer's Disease.

Published in:

2013

By:

Grossberg, George;
Cummings, Jeffrey;
Frölich, Lutz;
Bellelli, Giuseppe;
Molinuevo, José L.;
Krahnke, Tillmann;
Strohmaier, Christine

Publication type:

Journal Article

Neuroprotective Effect of Valeric Acid in Combination with Piracetam and Rivastigmine by Evaluating the Expression of Caspase 3 in Alzheimer’s Disease Induced Rats.

Published in:

Frontiers in Health Informatics, 2024, v. 13, n. 7, p. 385

By:

D., Blessina Sugandhi;
S., Bindhu;
S., Nidhi;
Kumar, Shishir;
Panda, Dhiren Kumar

Publication type:

Article

Risk of Antipsychotic Initiation Among Older Dementia Patients Initiating Cholinesterase Inhibitors.

Published in:

Drug, Healthcare & Patient Safety, 2025, v. 17, p. 75, doi. 10.2147/DHPS.S506523

By:

Chikermane, Soumya G;
Li, Jieni;
Aparasu, Rajender R

Publication type:

Article

Alzheimer Disease.

Published in:: Psychiatric Times, 2023, v. 40, n. 3, p. 7
Publication type:: Article

The effects of rivastigmine on neuropsychiatric symptoms in the early stages of Parkinson's disease: A systematic review.

Published in:

European Journal of Neurology, 2024, v. 31, n. 2, p. 1, doi. 10.1111/ene.16142

By:

Reilly, Siobhan;
Dhaliwal, Simran;
Arshad, Usman;
Macerollo, Antonella;
Husain, Nusrat;
Costa, Antonio Da

Publication type:

Article

3-((2-(4-Chloro-5-ethoxy-2-nitrophenoxy)acetamido)methyl)phenyl-dimethylcarbamate.

Published in:

Molbank, 2024, v. 2024, n. 3, p. M1863, doi. 10.3390/M1863

By:

Leuci, Rosalba;
Dininno, Daniela;
Paparella, Marco;
Piemontese, Luca

Publication type:

Article

Cognitive Benefit of Rivastigmine in Parkinson's Disease Dementia with Orthostatic Hypotension.

Published in:

Neurology Alert, 2021, v. 40, n. 6, p. 1

By:

AHC MEDIA

Publication type:

Article

Treatment of pediatric antimuscarinic delirium with oral rivastigmine.

Published in:

Oxford Medical Case Reports, 2023, v. 2023, n. 9, p. 1, doi. 10.1093/omcr/omad096

By:

Yakey, Brandtly;
Vohra, Varun;
Martin, Amarilis;
King, Andrew M

Publication type:

Article

Rivastigmine Regulates the HIF-1α/VEGF Signaling Pathway to Induce Angiogenesis and Improves the Survival of Random Flaps in Rats.

Published in:

Frontiers in Pharmacology, 2022, v. 12, p. 1, doi. 10.3389/fphar.2021.818907

By:

Liu, Yingying;
Li, Wenjie;
Ma, Xinyi;
He, Jibing;
Lin, Yi;
Lin, Dingsheng

Publication type:

Article

Randomised multicentre trial on safety and efficacy of rivastigmine in cognitively impaired multiple sclerosis patients.

Published in:

Multiple Sclerosis Journal, 2013, v. 19, n. 5, p. 631, doi. 10.1177/1352458512463481

By:

Mäurer, M;
Ortler, S;
Baier, M;
Meergans, M;
Scherer, P;
Hofmann, WE;
Tracik, F

Publication type:

Article

Rivastigmine for treatment-refractory posttraumatic stress disorder: a systematic review.

Published in:

East Asian Archives of Psychiatry, 2024, v. 34, n. 2, p. 29, doi. 10.12809/eaap2353

By:

Maguire, Paul A.;
Bastiampillai, Tarun;
Allison, Stephen;
Wilkes, Fiona;
Looi, Jeffrey C. L.

Publication type:

Article